<bill session="117" type="s" number="2149" updated="2022-12-31T05:26:47Z">
  <state datetime="2021-06-21">REFERRED</state>
  <status>
    <introduced datetime="2021-06-21"/>
  </status>
  <introduced datetime="2021-06-21"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests, to increase participation in colorectal cancer screening in under-screened communities of color, to offset the COVID-19 pandemic driven declines in colorectal cancer screening, and for other purposes.</title>
    <title type="display">Donald Payne, Sr., Colorectal Cancer Detection Act of 2021</title>
    <title type="short" as="introduced">Donald Payne, Sr., Colorectal Cancer Detection Act of 2021</title>
  </titles>
  <sponsor bioguide_id="H001046"/>
  <cosponsors>
    <cosponsor bioguide_id="P000145" joined="2021-06-21"/>
    <cosponsor bioguide_id="W000437" joined="2021-06-21"/>
  </cosponsors>
  <actions>
    <action datetime="2021-06-21">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-06-21" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="1655" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Cancer"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2021-07-08T22:12:31Z" status="Introduced in Senate">Donald Payne Sr. Colorectal Cancer Detection Act of 2021

This bill provides for Medicare coverage and payment, subject to&#160;specified frequency limits, of certain colorectal cancer screening blood-based tests.</summary>
</bill>
